News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
145–180
Matches
673
Sources here
18
Companies here
18
Search results Stored financial headlines

Active search

673 matching headlines

Ticker or company: ARINMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Earnings Flash (BMRN) BioMarin Pharmaceutical Inc. Posts Q2 Adjusted EPS $1.20 per Share, vs. FactSet Est of $0.95

BioMarin Pharmaceutical Inc. (BMRN) reported Q2 adjusted EPS of $1.20 per share, surpassing the FactSet estimate of $0.95. The company also announced Q2 revenue of $990.0 million, exceeding the FactSet estimate of $932.0 million, and provided updated earnings guidance for the full year 2026. …

BMRN main company
Sharemaestro market context Trend signal active 52 weeks +15.0% BMRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioMarin earnings on deck as flagship drug faces competition

BioMarin Pharmaceutical Inc. is set to report second-quarter earnings, with analysts expecting 95 cents per share on $939.2 million in revenue, an increase from the previous quarter. The upcoming earnings call will likely focus on the competitive landscape for its top drug, VOXZOGO, which …

BMRN main company
Sharemaestro market context Trend signal active 52 weeks +15.0% BMRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BioMarin Pharmaceutical Q2 Earnings Call Highlights

BioMarin Pharmaceutical's Q2 revenue approached $1 billion, a 20% increase year-over-year, driven by its rare-disease portfolio and the Amicus acquisition. The company raised its full-year guidance for revenue, VOXZOGO revenue, and non-GAAP EPS, projecting significant growth from Amicus therapies and VOXZOGO becoming a $1 …

BMRN main company
Sharemaestro market context Trend signal active 52 weeks +15.0% BMRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MarineMax, Inc. Just Beat Revenue Estimates By 5.2%

MarineMax, Inc. (NYSE:HZO) exceeded revenue estimates by 5.2%, reporting US$758m, and statutory earnings per share (EPS) of US$1.37, which was 2.8% above expectations. Analysts have increased their EPS forecasts for 2025 by 46% to US$3.23 and raised the consensus price target by 29% to …

HZO main company
Sharemaestro market context Trend signal active 52 weeks +85.3% · Next-week setup negative 41.2% HZO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barinthus Biotherapeut reports Q2 2026 net loss $10.6M, cash $59.6M; VTP-1000 MAD data due Q4 2026

Barinthus Biotherapeutics reported a Q2 2026 net loss of $10.6 million and held $59.6 million in cash. The company completed enrollment for the VTP-1000 Phase 1 AVALON trial's multiple ascending dose portion, with topline data expected in Q4 2026. A proposed combination with Clywedog …

BRNS main company
Sharemaestro market context Price below Trend Line 52 weeks -49.9% BRNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barinthus Biotherapeutics plc. 2026: Revenue ($9.78M), Net income ($10.58M), EPS ($0.26) — 10-Q Summary

Barinthus Biotherapeutics plc. (BRNS) reported a narrower comprehensive loss in the 2026 quarter, driven by cost reductions and pipeline reprioritization towards immunology and inflammation programs. The company also completed enrollment for a Phase 1 clinical trial and entered a merger agreement with Clywedog, with …

BRNS main company
Sharemaestro market context Price below Trend Line 52 weeks -49.9% BRNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barings BDC Inc 2026 Q2 - Results - Earnings Call Presentation (NYSE:BBDC) 2026-08-06

Barings BDC Inc (NYSE:BBDC) released its Q2 2026 earnings call presentation on August 6, 2026. The company reported an EPS of $0.28, beating estimates by $0.04, and revenue of $65.20M, exceeding expectations by $5.10M despite a 12.36% year-over-year decrease. This presentation was published in …

BBDC main company
Sharemaestro market context Trend signal active 52 weeks +8.4% BBDC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Barinthus Bio announced its second quarter 2026 financial results and provided updates on corporate developments, including the progressing proposed combination with Clywedog Therapeutics Inc. The company completed enrollment for the Phase 1 AVALON trial of VTP-1000 for celiac disease, with topline data expected in …

BRNS main company
Sharemaestro market context Price below Trend Line 52 weeks -49.9% BRNS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings Flash (BBDC) Barings BDC, Inc. Reports Q2 Total Investment Income $65.2M, Vs. FactSet Est of $60.1M

Barings BDC, Inc. (BBDC) announced its Q2 earnings, reporting a total investment income of $65.2 million. This figure exceeded FactSet's estimate of $60.1 million, indicating stronger financial performance than anticipated.

BBDC main company
Sharemaestro market context Trend signal active 52 weeks +8.4% BBDC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barings Bdc, Inc. to Issue Quarterly Dividend of $0.26 (NYSE:BBDC)

Barings Bdc, Inc. (NYSE:BBDC) announced a quarterly dividend of $0.26 per share, payable on September 9th to shareholders of record on September 2nd. This dividend represents an annualized yield of 12.4%, but the company's dividend payout ratio of 105.1% suggests it cannot cover the …

BBDC main company
Sharemaestro market context Trend signal active 52 weeks +8.4% BBDC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Results: RBC Bearings Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates

RBC Bearings Incorporated (NYSE:RBC) recently reported strong quarterly results, with revenues surpassing expectations by 2.0% and statutory earnings per share exceeding forecasts by 13%. Despite the positive performance, analysts have largely maintained their future estimates and price targets, indicating no major shift in their …

RBC main company
Sharemaestro market context Trend signal ended 52 weeks +39.6% · Next-week setup positive 72.2% RBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Dimensional Fund Advisors LP Cuts Stock Position in MarineMax, Inc. $HZO

Dimensional Fund Advisors LP reduced its stake in MarineMax, Inc. (NYSE:HZO) by 7.5% in the first quarter, selling over 78,000 shares but retaining a significant holding worth approximately $26.2 million. Other institutional investors also adjusted their positions in the company, which is 92.85% owned …

HZO main company
Sharemaestro market context Trend signal active 52 weeks +85.3% · Next-week setup negative 41.2% HZO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Odyssey Marine (Nasdaq: OMEX) details exploration-stage seabed mining stakes

Odyssey Marine Exploration, Inc. (OMEX) filed Amendment No. 2 to its 2025 annual report, clarifying its mineral property disclosures in response to an SEC comment. The amendment specifies that its mining operations are material, detailing indirect, minority interests in exploration-stage projects like CIC Limited …

OMEX main company
Sharemaestro market context Price below Trend Line 52 weeks -36.6% OMEX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bank of Marin Bancorp (BMRC) EVP reports 604-share tax withholding at $29.16

David A. Bloom, Executive Vice President of Bank of Marin Bancorp (BMRC), reported an F-code transaction involving the disposition of 604 shares of common stock on July 31, 2026. These shares, valued at $29.16 each, were withheld to satisfy tax liabilities, rather than being …

BMRC main company
Sharemaestro market context Trend signal active 52 weeks +20.0% BMRC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barings BDC, Inc. Q2 2026: Revenue $65.2M, EPS $0.18— 10-Q Summary

Barings BDC, Inc. reported its Q2 2026 financial results, showing investment income of $65.2 million and a net increase in net assets from operations of $18.3 million, or $0.18 per share. These figures represent a modest decline compared to the previous year, attributed to …

BBDC main company
Sharemaestro market context Trend signal active 52 weeks +8.4% BBDC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Q1 2025 Amarin Corporation PLC Earnings Call Transcript

Amarin Corporation PLC's Q1 2025 earnings call transcript reveals mixed results. The company achieved significant progress in extending European IP protection, expanding global presence for VESCEPA, and maintaining a debt-free balance sheet. However, total net revenue and U.S. product revenue declined due to generic …

AMARIN main company AMRN main company
Sharemaestro market context Price below Trend Line 52 weeks +20.0% · Next-week setup negative 31.2% AMARIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

BBDC: NAV per share fell to $10.94, with strong income and a stable dividend maintained

Barings BDC (BBDC) reported a decline in NAV per share to $10.94 due to unrealized depreciation, yet maintained a strong net investment income of $0.28 per share. The portfolio yield remained robust at 10.2%, and the company successfully upheld its regular dividend for the …

BBDC main company
Sharemaestro market context Trend signal active 52 weeks +8.4% BBDC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SEACOR Marine General Counsel Andrew H. Everett II sells 6,131 common shares worth $58,540.96

SEACOR Marine's General Counsel, Andrew H. Everett II, sold 6,131 common shares for $58,540.96 between August 3-4, 2026, at prices of $9.52 and $9.56 per share. This sale reduced his direct stake to 198,595 shares. The information for this report was generated by AI …

SMHI main company
Sharemaestro market context Trend signal active 52 weeks +51.2% SMHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barings BDC made 21 new investments totaling $172.1M in Q2

Barings BDC, Inc. (BBDC) reported its second quarter 2026 financial results, announcing a quarterly cash dividend of $0.26 per share. The company generated strong earnings, over-earning its dividend, and made 21 new portfolio investments totaling $172.1 million, alongside $90.0 million in existing portfolio companies. …

BBDC main company
Sharemaestro market context Trend signal active 52 weeks +8.4% BBDC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OneWater Marine Inc. Just Missed Earnings - But Analysts Have Updated Their Models

OneWater Marine Inc. missed its third-quarter revenue and EPS expectations, with revenue 4.2% below models and EPS falling short by 10%. Despite this, analysts have become slightly more optimistic for 2027, upgrading EPS forecasts while slightly decreasing revenue expectations. The average price target remains …

ONEW main company
Sharemaestro market context Trend signal started 52 weeks -31.1% ONEW stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Royal Bank of Canada Decreases Stock Holdings in RBC Bearings Incorporated $RBC

Royal Bank of Canada reduced its stake in RBC Bearings Incorporated by 13.7% in the first quarter, selling 7,599 shares but still holding 47,691 shares valued at $25.9 million. Despite this reduction, analyst sentiment for RBC Bearings remains largely positive, with a "Moderate Buy" …

RBC main company
Sharemaestro market context Trend signal ended 52 weeks +39.6% · Next-week setup positive 72.2% RBC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

SEACOR Marine (NYSE: SMHI) insider sells 6,131 shares under 10b5-1 plan

An executive at SEACOR Marine Holdings Inc. (NYSE: SMHI), Everett Andrew H II, sold a total of 6,131 shares of common stock on August 3-4, 2026. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 9, 2026, at weighted …

SMHI main company
Sharemaestro market context Trend signal active 52 weeks +51.2% SMHI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context